{'52WeekChange': 0.25570774,
 'SandP52WeekChange': 0.0644362,
 'address1': '5200 Illumina Way',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 394,
 'askSize': 800,
 'averageDailyVolume10Day': 899587,
 'averageVolume': 926425,
 'averageVolume10days': 899587,
 'beta': 0.994397,
 'beta3Year': None,
 'bid': 376.01,
 'bidSize': 800,
 'bookValue': 31.531,
 'category': None,
 'circulatingSupply': None,
 'city': 'San Diego',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 385,
 'dayLow': 376.625,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': -0.258,
 'enterpriseToEbitda': 45.703,
 'enterpriseToRevenue': 15.397,
 'enterpriseValue': 54751748096,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '858 202 4545',
 'fiftyDayAverage': 368.32828,
 'fiftyTwoWeekHigh': 402.14,
 'fiftyTwoWeekLow': 196.78,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 146395830,
 'forwardEps': 7.68,
 'forwardPE': 49.772137,
 'fromCurrency': None,
 'fullTimeEmployees': 7700,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.00337,
 'heldPercentInstitutions': 0.96208,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577577600,
 'lastMarket': None,
 'lastSplitDate': 1222128000,
 'lastSplitFactor': '2:1',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/illumina.com',
 'longBusinessSummary': 'Illumina, Inc. provides sequencing and array-based '
                        'solutions for genetic and genomic analysis. Its '
                        'products and services serve customers in a range of '
                        'markets enabling the adoption of genomic solutions in '
                        'research and clinical settings for applications in '
                        'the life sciences, oncology, reproductive health, '
                        'agriculture and other emerging segments. The company '
                        'provides instruments and consumables used in genetic '
                        'analysis; and genotyping and sequencing services, '
                        'instrument service contracts, and development and '
                        'licensing agreements. Its customers include genomic '
                        'research centers, academic institutions, government '
                        'laboratories, and hospitals, as well as '
                        'pharmaceutical, biotechnology, commercial molecular '
                        'diagnostic laboratories, and consumer genomics '
                        'companies. The company markets and distributes its '
                        'products directly to customers in North America, '
                        'Europe, Latin America, and the Asia-Pacific region, '
                        'as well as sells through life-science distributors in '
                        'certain markets within Europe, the Asia-Pacific '
                        'region, Latin America, the Middle East, and Africa. '
                        'Illumina, Inc. was founded in 1998 and is '
                        'headquartered in San Diego, California.',
 'longName': 'Illumina, Inc.',
 'market': 'us_market',
 'marketCap': 56190750720,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_29753',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585440000,
 'navPrice': None,
 'netIncomeToCommon': 942000000,
 'nextFiscalYearEnd': 1640736000,
 'open': 385,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 6.06,
 'phone': '858 202 4500',
 'previousClose': 386.45,
 'priceHint': 2,
 'priceToBook': 12.12299,
 'priceToSalesTrailing12Months': 15.801674,
 'profitMargins': 0.2649,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 385,
 'regularMarketDayLow': 376.625,
 'regularMarketOpen': 385,
 'regularMarketPreviousClose': 386.45,
 'regularMarketPrice': 385,
 'regularMarketVolume': 537910,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 147000000,
 'sharesPercentSharesOut': 0.023599999,
 'sharesShort': 3467953,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2955958,
 'shortName': 'Illumina, Inc.',
 'shortPercentOfFloat': 0.0269,
 'shortRatio': 4.12,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'ILMN',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 6.343,
 'trailingPE': 60.263283,
 'twoHundredDayAverage': 317.4726,
 'volume': 537910,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.illumina.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92122'}